VT News

Takahiro Sekine

Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • UK and France announce new migrant returns deal, but its limited scale draws criticism amid ongoing Channel crossings.
  • Tragic fire in hyperbaric chamber claims life of Arizona therapist
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • UK and France announce new migrant returns deal, but its limited scale draws criticism amid ongoing Channel crossings.
  • Tragic fire in hyperbaric chamber claims life of Arizona therapist
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Takahiro Sekine

Top Topics

Trending in U.S.

World

Sport